1.An up-to-date review of emerging biologic therapies for hypercholesterolemia
Tomlinson, B
EXPERT OPINION ON BIOLOGICAL THERAPY[1471-2598], Published 2025, Volume 25, Issue 1, Pages 69-78
收錄情况: WOS SCOPUS
WOS核心合集引用: 0 2023影響因子: 3.6
2.Exploring emerging pharmacotherapies for type 2 diabetes patients with hypertriglyceridemia
Tomlinson, B, Chan, More...
EXPERT OPINION ON PHARMACOTHERAPY[1465-6566], Published 2025, Volume 26, Issue 3, Pages 279-289
收錄情况: WOS SCOPUS
WOS核心合集引用: 0 2023影響因子: 2.5
Wang, YF, Wang, XY, More...
ADVANCED SCIENCE[2198-3844], Published 2025, Volume 12, Issue 12,
收錄情况: WOS SCOPUS
WOS核心合集引用: 1 2023影響因子: 14.3
Elshorbagy, A, Valle More...
EUROPEAN HEART JOURNAL[0195-668X], Published 2025, Volume 46, Issue 12, Pages 1127-1140
收錄情况: WOS SCOPUS
WOS核心合集引用: 3 2023影響因子: 38.1
5.Advances in Dyslipidaemia Treatments: Focusing on ApoC3 and ANGPTL3 Inhibitors
Tomlinson, Brian, Wu More...
Journal of Lipid and Atherosclerosis[2287-2892], Published 2024, Volume 13, Issue 1, Pages 2-20
收錄情况: SCOPUS
Jin, Q, Lau, ESH, Lu More...
DIABETOLOGIA[0012-186X], Published 2024, Volume 67, Issue 5, Pages 837-849
收錄情况: WOS SCOPUS
WOS核心合集引用: 6 2023影響因子: 8.4
7.Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
Suzuki, K, Hatzikoto More...
NATURE[0028-0836], Published 2024, Volume 627, Issue 8003, Pages 347-357
收錄情况: WOS SCOPUS
WOS核心合集引用: 105 2023影響因子: 50.5
Tomlinson, B, Chan, More...
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY[1742-5255], Published 2024, Volume 20, Issue 4, Pages 175-179
收錄情况: WOS SCOPUS
WOS核心合集引用: 2 2023影響因子: 3.9
Tomlinson, B, Chow, More...
HONG KONG MEDICAL JOURNAL[1024-2708], Published 2024, Volume 30, Issue 2, Pages 184-185
收錄情况: WOS SCOPUS
WOS核心合集引用: 1 2023影響因子: 3.1
Zeng, WW, Chu, TTW, More...
HELIYON[2405-8440], Published 2024, Volume 10, Issue 14,
收錄情况: WOS SCOPUS
WOS核心合集引用: 1 2023影響因子: 3.4
Pi, JJ, Chang, H, Ch More...
REDOX BIOLOGY[2213-2317], Published 2024, Volume 75,
收錄情况: WOS SCOPUS
WOS核心合集引用: 2 2023影響因子: 10.7
12.Options for patients with out-of-control blood pressure: after all avenues have been exhausted
Zeng, WW, Tomlinson, More...
EXPERT REVIEW OF CARDIOVASCULAR THERAPY[1477-9072], Published 2024,
收錄情况: WOS SCOPUS
WOS核心合集引用: 0 2023影響因子: 1.8
Zeng, WW, Chu, TTW, More...
DOSE-RESPONSE[1559-3258], Published 2024, Volume 22, Issue 4,
收錄情况: WOS SCOPUS
WOS核心合集引用: 0 2023影響因子: 2.3
14.Statin alternatives for the treatment of hypercholesterolemia - a safety evaluation
Zeng, WW, Tomlinson, More...
EXPERT OPINION ON DRUG SAFETY[1474-0338], Published 2024,
收錄情况: WOS SCOPUS
WOS核心合集引用: 2 2023影響因子: 3.0
15.Advances in statin adverse reactions and the potential mechanisms: A systematic review
Zeng, Weiwei, Deng, More...
Journal of Advanced Research[2090-1232], Published 2024,
收錄情况: SCOPUS
2023影響因子: 11.4
Elshorbagy, A, Lyons More...
LANCET DIABETES & ENDOCRINOLOGY[2213-8587], Published 2024, Volume 12, Issue 11, Pages 811-823
收錄情况: WOS SCOPUS
WOS核心合集引用: 3 2023影響因子: 44.0
17.Pharmacogenomics: The roles of genetic factors on treatment response and outcomes in diabetes
Wang, Ke, Chow, Elai More...
Internet of Things and Machine Learning for Type I and Type II Diabetes: Use Cases, Published 2024, Pages 367-395
收錄情况: SCOPUS
Brian Tomlinson
The Hong Kong Medical Diary: Clinical Pharmacology[1812-1691], Published 2024, Volume 29, Issue 12, Pages 2
19.Management of Resistant Hypertension
Brian TOMLINSON, Iat More...
The Hong Kong Medical Diary: Clinical Pharmacology[1812-1691], Published 2024, Volume 29, Issue 12, Pages 4-7
20.Hypertension Management - the Role of Beta-blockers
Yu-tak HUNG, Brian T More...
The Hong Kong Medical Diary: Clinical Pharmacology[1812-1691], Published 2024, Volume 29, Issue 12, Pages 13, 16
本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器
Copyright © 2018 澳門科技大學學者庫